SCHEMBL13457574

SCHEMBL13457574

CC(=O)c1cc(C)ncc1NS(=O)(=O)c1ccc(N)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 4/20 0.50
▸ SMN1; SMN2 Q16637 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CCR9 P51686 3/20 0.48
▸ LMNA P02545 3/20 0.47
▸ HPGD P15428 1/20 0.47
▸ MAPT P10636 2/20 0.47
▸ PDE4A P27815 1/20 0.47
▸ AGO2 Q9UKV8 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ EDNRA P25101 1/20 0.47
▸ DHFR P00374 2/20 0.46
▸ TSHR P16473 2/20 0.46
▸ TERT O14746 1/20 0.45
▸ ADRA1A P35348 1/20 0.45
▸ POLB P06746 1/20 0.44
▸ AURKA O14965 2/20 0.43
▸ HTR6 P50406 1/20 0.43
▸ MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13457662 0.86 LMNA (0.46) TDP1SMN1; SMN2ALDH1A1CYP3A4CCR9
SCHEMBL11405994 0.73 CRHBP (0.53) TDP1SMN1; SMN2ALDH1A1CYP3A4LMNA
SCHEMBL9007875 0.71 ALDH1A1 (0.52) TDP1SMN1; SMN2ALDH1A1CYP3A4LMNA
SCHEMBL2184586 0.71 MEN1 (0.48) TDP1ALDH1A1CYP3A4CCR9LMNA
SCHEMBL30354985 0.71 CA1 (0.57) TDP1SMN1; SMN2ALDH1A1CYP3A4LMNA
SCHEMBL29151297 0.71 CA1 (0.57) TDP1SMN1; SMN2ALDH1A1CYP3A4LMNA
Sulfamethazine SCHEMBL28447030 0.70 ALDH1A1 (0.86) TDP1SMN1; SMN2ALDH1A1CYP3A4LMNA
SCHEMBL2177837 0.70 CYP2C19 (0.68) TDP1SMN1; SMN2ALDH1A1CYP3A4LMNA
SCHEMBL5317017 0.69 HDAC3 (0.56) TDP1SMN1; SMN2LMNACYP2C9DHFR
SCHEMBL23461180 0.69 PIK3CD (0.49) TDP1SMN1; SMN2ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010026121-A1 BICYCLIC KINASE INHIBITORS NOVARTIS AG (CH) 2010-03-11 — — WO disclosed
Send feedback